Francesca Wuttke

Nowhere is it more critical to have the ability to use ALL available data than within healthcare. Clinithink's solutions transform unstructured clinical narrative into structured patient information. Whether it’s to better understand a vulnerable population, highlight important phenotypes or to reduce the risk of denied claims for providers, Clinithink’s solutions provide healthcare decision-makers with better information and insight. Founded in 2009 on the premise that unlocking unstructured clinical data within patient records and returning it as structured, usable clinical information cracks wide open the realm of possibilities to solve the toughest challenges in healthcare. Within the Clinithink team, we bring together ‘thinkers’ and ‘doers’ who contribute to our knowledge base, build best-in-class solutions and expand our footprint in target markets where opportunities are plentiful. ‘Clinithinkers’ are self-motivated, focused, passionate and excited about changing the technology landscape by evolving cutting-edge approaches to solve tough business problems using unstructured data. Clinithink offers a competitive salary and benefits package for its UK and US employees, together with support for ongoing personal development. Spanning the UK and the US, we have offices in Bridgend, London and Alpharetta and we are looking for experienced, committed, creative, hard-working and ambitious individuals to join our team. If you have what it takes to be a Clinithinker, contact careers@clinithink.com.

Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. Were based in New York, NY and London, U.K. For more information, visit http://www.antidote.me.

nen offers a novel mission-driven approach, designed for kid’s minds, to address their particular needs. The philosophy behind nen is that, through play, we can apply tools that we know work in the context of cognitive behavioral therapy (CBT) to modulate pain and improve their overall wellbeing and outcomes.

Nowhere is it more critical to have the ability to use ALL available data than within healthcare. Clinithink's solutions transform unstructured clinical narrative into structured patient information. Whether it’s to better understand a vulnerable population, highlight important phenotypes or to reduce the risk of denied claims for providers, Clinithink’s solutions provide healthcare decision-makers with better information and insight. Founded in 2009 on the premise that unlocking unstructured clinical data within patient records and returning it as structured, usable clinical information cracks wide open the realm of possibilities to solve the toughest challenges in healthcare. Within the Clinithink team, we bring together ‘thinkers’ and ‘doers’ who contribute to our knowledge base, build best-in-class solutions and expand our footprint in target markets where opportunities are plentiful. ‘Clinithinkers’ are self-motivated, focused, passionate and excited about changing the technology landscape by evolving cutting-edge approaches to solve tough business problems using unstructured data. Clinithink offers a competitive salary and benefits package for its UK and US employees, together with support for ongoing personal development. Spanning the UK and the US, we have offices in Bridgend, London and Alpharetta and we are looking for experienced, committed, creative, hard-working and ambitious individuals to join our team. If you have what it takes to be a Clinithinker, contact careers@clinithink.com.

Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. Were based in New York, NY and London, U.K. For more information, visit http://www.antidote.me.

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Almirall is a global biopharmaceutical company focused on medical dermatology. Founded in 1944 and with headquarters in Barcelona (Spain), our purpose is at the core of our work: “Transform the patients’ world by helping them realize their hopes and dreams for a healthy life”. Through pharmaceutical innovation, investment in R&D and strong commitment to global healthcare partnerships, we develop and commercialize solutions with specific focus on dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis or acne. We care and listen to our patients’ needs. We find solutions for them. We aim to empower them. Almirall has 1 R&D center, 2 chemical plants and 2 pharmaceutical plants. Our more than 1,900 employees make it possible for our treatments to be available in over 100 countries across 5 continents, through our 15 global affiliates and via a strategic partnership network. Almirall is listed on the Spanish Stock Exchange (ticker: ALM).